Houlihan Lokey - HLI Stock Price Target and Predictions

  • Consensus Rating: Reduce
  • Consensus Price Target: $174.20
  • Forecasted Upside: 0.13%
  • Number of Analysts: 6
  • Breakdown:
  • 2 Sell Ratings
  • 3 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$173.97
▲ +1.23 (0.71%)

This chart shows the closing price for HLI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Houlihan Lokey Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HLI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HLI

Analyst Price Target is $174.20
▲ +0.13% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Houlihan Lokey in the last 3 months. The average price target is $174.20, with a high forecast of $200.00 and a low forecast of $129.00. The average price target represents a 0.13% upside from the last price of $173.97.

This chart shows the closing price for HLI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Reduce

The current consensus among 6 investment analysts is to reduce stock in Houlihan Lokey. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 1 sell ratings
6/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/27/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/26/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/25/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/23/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 1 sell ratings
9/21/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 1 sell ratings
11/20/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 2 sell ratings
12/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/20/2024Keefe, Bruyette & WoodsBoost TargetMarket Perform ➝ Market Perform$171.00 ➝ $172.00
12/12/2024Wells Fargo & CompanyBoost TargetUnderweight ➝ Underweight$157.00 ➝ $180.00
12/9/2024Morgan StanleyDowngradeEqual Weight ➝ Underweight$171.00 ➝ $200.00
10/8/2024UBS GroupBoost TargetBuy ➝ Buy$170.00 ➝ $190.00
9/23/2024Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$146.00 ➝ $163.00
9/18/2024Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$148.00 ➝ $146.00
9/12/2024Wells Fargo & CompanyInitiated CoverageUnderweight$149.00
7/31/2024JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$132.00 ➝ $129.00
7/31/2024UBS GroupBoost TargetBuy ➝ Buy$157.00 ➝ $170.00
7/31/2024Keefe, Bruyette & WoodsReiterated RatingMarket Perform ➝ Market Perform$139.00 ➝ $154.00
7/23/2024Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$131.00 ➝ $148.00
7/12/2024Keefe, Bruyette & WoodsBoost TargetMarket Perform ➝ Market Perform$132.00 ➝ $139.00
7/9/2024UBS GroupBoost TargetBuy ➝ Buy$145.00 ➝ $157.00
5/14/2024UBS GroupLower TargetBuy ➝ Buy$157.00 ➝ $145.00
4/9/2024JMP SecuritiesReiterated RatingMarket Perform
2/2/2024UBS GroupBoost TargetBuy ➝ Buy$136.00 ➝ $142.00
1/29/2024Keefe, Bruyette & WoodsReiterated RatingMarket Perform$127.00
1/9/2024UBS GroupBoost TargetBuy ➝ Buy$124.00 ➝ $136.00
10/3/2023UBS GroupBoost TargetBuy ➝ Buy$118.00 ➝ $124.00
7/12/2023Morgan StanleyBoost Target$81.00 ➝ $101.00
1/3/2023Keefe, Bruyette & WoodsBoost TargetMarket Perform$90.00 ➝ $95.00
10/31/2022Morgan StanleyBoost TargetEqual Weight$75.00 ➝ $78.00
7/29/2022UBS GroupLower TargetBuy$105.00 ➝ $102.00
7/18/2022Morgan StanleyUpgradeUnderweight ➝ Equal Weight$95.00 ➝ $82.00
7/8/2022Piper SandlerLower TargetUnderweight$80.00 ➝ $78.00
5/23/2022The Goldman Sachs GroupLower TargetBuy$106.00 ➝ $95.00
4/12/2022The Goldman Sachs GroupLower TargetBuy$127.00 ➝ $111.00
4/7/2022Piper SandlerDowngradeNeutral ➝ Underweight$92.00 ➝ $76.00
3/25/2022Morgan StanleyLower TargetUnderweight$97.00 ➝ $95.00
3/22/2022Piper SandlerLower TargetNeutral$106.00 ➝ $92.00
3/9/2022Piper SandlerLower TargetNeutral$122.00 ➝ $106.00
3/8/2022Morgan StanleyLower TargetUnderweight$106.00 ➝ $97.00
2/9/2022Morgan StanleyBoost TargetUnderweight$101.00 ➝ $106.00
1/11/2022Morgan StanleyBoost TargetUnderweight$97.00 ➝ $101.00
1/6/2022The Goldman Sachs GroupUpgradeNeutral ➝ Buy$116.00 ➝ $126.00
1/4/2022CitigroupUpgradeNeutral ➝ Buy
1/4/2022UBS GroupUpgradeNeutral ➝ Buy$120.00 ➝ $116.00
12/8/2021Morgan StanleyLower TargetUnderweight ➝ Underweight$106.00 ➝ $97.00
10/29/2021Morgan StanleyBoost TargetUnderweight$103.00 ➝ $106.00
10/29/2021Keefe, Bruyette & WoodsUpgradeUnderperform ➝ Market Perform$86.00 ➝ $110.00
10/26/2021JMP SecuritiesReiterated RatingHold ➝ Hold
7/14/2021Keefe, Bruyette & WoodsDowngradeMarket Perform ➝ Underperform$80.00
3/25/2021The Goldman Sachs GroupReiterated RatingBuy ➝ Neutral$82.00 ➝ $73.00
3/19/2021The Goldman Sachs GroupDowngradeBuy ➝ Neutral$82.00 ➝ $73.00
1/29/2021Morgan StanleyLower TargetUnderweight$80.00 ➝ $77.00
1/5/2021Wolfe ResearchDowngradePeer Perform ➝ Underperform$57.00 ➝ $63.00
12/14/2020Morgan StanleyDowngradeEqual Weight ➝ Underweight$80.00
10/12/2020Morgan StanleyBoost TargetEqual Weight$62.00 ➝ $65.00
10/2/2020UBS GroupDowngradeBuy ➝ Neutral$60.00
7/22/2020Wolfe ResearchInitiated CoveragePeer Perform$60.00
7/10/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$66.00 ➝ $57.00
5/13/2020Morgan StanleyBoost TargetEqual Weight$58.00 ➝ $62.00
5/13/2020UBS GroupBoost TargetBuy$55.00 ➝ $66.00
4/9/2020Morgan StanleyBoost TargetEqual Weight$52.00 ➝ $58.00
3/25/2020UBS GroupLower TargetBuy$59.00 ➝ $55.00
1/26/2020Keefe, Bruyette & WoodsDowngradeOutperform ➝ Market Perform$52.00 ➝ $53.00
1/13/2020Buckingham ResearchBoost TargetBuy$51.00 ➝ $57.00
(Data available from 12/21/2019 forward)

News Sentiment Rating

1.39 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 17 very positive mentions
  • 12 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
5/25/2024
  • 18 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/24/2024
  • 12 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/24/2024
  • 14 very positive mentions
  • 19 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/23/2024
  • 24 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/22/2024
  • 16 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/22/2024
  • 24 very positive mentions
  • 17 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/21/2024
  • 31 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/21/2024

Current Sentiment

  • 31 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Houlihan Lokey logo
Houlihan Lokey, Inc., an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory. The Corporate Finance segment offers general financial advisory services; and advises public and private institutions on buy-side and sell-side transactions, leveraged loans, private mezzanine debt, high-yield debt, initial public offerings, follow-ons, convertibles, equity private placements, private equity, and liability management transactions, as well as advise financial sponsors on various transactions. The Financial Restructuring segment advises debtors, creditors, and other parties-in-interest related to recapitalization/deleveraging transactions. It also provides a range of advisory services, including structuring, negotiation, and confirmation of plans of reorganization; structuring and analysis of exchange offers; corporate viability assessment; dispute resolution and expert testimony; and procuring debtor-in-possession financing. The Financial and Valuation Advisory segment offers valuations of various assets, such as companies, illiquid debt and equity securities, and intellectual property. It also provides fairness opinions in connection with M&A and other transactions, solvency opinions in connection with corporate spin-offs and dividend recapitalizations, and other types of financial opinions. In addition, this segment offers dispute resolution services. It serves corporations, financial sponsors, and government agencies. The company was incorporated in 1972 and is headquartered in Los Angeles, California.
Read More

Today's Range

Now: $173.97
Low: $170.00
High: $175.94

50 Day Range

MA: $178.84
Low: $164.68
High: $190.49

52 Week Range

Now: $173.97
Low: $112.17
High: $192.10

Volume

1,371,242 shs

Average Volume

326,204 shs

Market Capitalization

$12.09 billion

P/E Ratio

35.58

Dividend Yield

1.33%

Beta

0.67

Frequently Asked Questions

What sell-side analysts currently cover shares of Houlihan Lokey?

The following sell-side analysts have issued research reports on Houlihan Lokey in the last twelve months: JMP Securities, JPMorgan Chase & Co., Keefe, Bruyette & Woods, Morgan Stanley, StockNews.com, UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for HLI.

What is the current price target for Houlihan Lokey?

0 Wall Street analysts have set twelve-month price targets for Houlihan Lokey in the last year. Their average twelve-month price target is $174.20, suggesting a possible upside of 0.1%. Morgan Stanley has the highest price target set, predicting HLI will reach $200.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $129.00 for Houlihan Lokey in the next year.
View the latest price targets for HLI.

What is the current consensus analyst rating for Houlihan Lokey?

Houlihan Lokey currently has 2 sell ratings, 3 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Reduce."
View the latest ratings for HLI.

What other companies compete with Houlihan Lokey?

How do I contact Houlihan Lokey's investor relations team?

Houlihan Lokey's physical mailing address is 10250 CONSTELLATION BLVD. 5TH FLOOR, LOS ANGELES CA, 90067. The financial services provider's listed phone number is (310) 788-5200 and its investor relations email address is [email protected]. The official website for Houlihan Lokey is www.hl.com. Learn More about contacing Houlihan Lokey investor relations.